Clinical trial
Tyrosine Kinase Inhibitors in the Management of Local Advanced or Metastastic Adenoid Cystic Carcinoma
NCT04974866 is registered in ClinicalTrials.gov with Qingdao Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tyrosine Kinase Inhibitors in the Management of Local Advanced or Metastastic Adenoid Cystic Carcinoma
- Lead sponsor
- Qingdao Central Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 1, 2021
- Completion date
- July 31, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.